A Multi-center, Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy of Subcutaneous Injections of the Myasthenia Gravis Active Targeted Immunotherapy CV-MG01 in Patients with Moderate to Severe Myasthenia Gravis - Myasterix Efficacy Phase 2/3 Study
100 项与 CuraVac Europe SA 相关的临床结果
0 项与 CuraVac Europe SA 相关的专利(医药)
100 项与 CuraVac Europe SA 相关的药物交易
100 项与 CuraVac Europe SA 相关的转化医学